$30.17
+9.78% past month
Notable price movement
Aug 26, 2026
$29.83-6.05%
Aug 25, 2026
$31.75+2.16%
The broad market rose +0.32% on the day, and the stock moved in the same direction, gaining +2.16% .
Aug 24, 2026
$31.08-7.99%
Seeking Alpha reported that the stock dipped 8% on reports of credit card disputes . Kessler Topaz Meltzer & Check, LLP announced it was investigating potential securities litigation claims against the company . The broad market fell only -0.29% on the same session, while the stock dropped -7.99% .
Aug 21, 2026
$33.78+6.03%
The stock gained +6.03% on a day when the broad market rose +0.41% . Seeking Alpha reported that the company was facing penalties from Visa related to credit card disputes , though the stock rose sharply despite that report.
Aug 20, 2026
$31.86+2.48%
The stock rose +2.48% on a day when the broad market fell -0.84%, a move not shared by the broad market .
Aug 19, 2026
$31.09+13.51%
The stock surged +13.51% on a day when the broad market rose only +0.21%, a move not shared by the broad market . Multiple Motley Fool reports noted that recent insider share disposals at the company were tied to RSU tax-withholding transactions rather than discretionary selling , and that one insider retained roughly 339,000 shares and additional derivative securities .
Aug 18, 2026
$27.39-4.26%
Yahoo Finance reported that the company was facing a new consumer class action lawsuit alleging misrepresentation of user privacy and unauthorized sharing of sensitive health data, following a recent FTC civil enforcement action . Kessler Topaz Meltzer & Check, LLP separately announced it was investigating potential securities litigation claims against the company . The stock fell -4.26% while the broad market declined -0.68% on the same session , with volume at 0.5x the trailing 20-session average .
Closing prices for HIMS. Summaries describe past sessions only and are not advice, a forecast or a recommendation.
Recent news
Headlines are published by third parties and linked as reported. Amaltash does not endorse or verify them.
Prices and financial data are historical and provided for research only. Not investment advice.